THERESA GAGLIARDO: Open Payments
NPI 1508613787 · MERRITT ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 28 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $345 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $240 |
| Exact Sciences Corporation | 4 | $96 |
| Amgen Inc. | 4 | $82 |
| ABBVIE INC. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Astellas Pharma US Inc | 1 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: Wegovy, The Cologuard Plus Collection Kit, EVENITY, UBRELVY, FARXIGA, CAPLYTA, Ozempic, QULIPTA.
Industry payments across FL — which companies pay providers there.
